Astrazeneca Pharma India's Stock Gains 7.11%, Outperforms Sector and Sensex

Astrazeneca Pharma India, a midcap pharmaceutical company, has been making headlines in the stock market with its recent performance. On September 24, 2024, the company's stock gained 7.11%, closing at Rs 7301.05. This has caught the attention of investors and analysts, with MarketsMOJO giving a 'Hold' call for the stock.

The stock is currently trading close to its 52-week high, with only a 4.44% difference. Today, it opened with a gain of 2.24% and reached an intraday high of Rs 7301.05, outperforming the sector by 6.8%. This positive trend is also reflected in the moving averages, with the stock trading higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In comparison to the Sensex, Astrazeneca Pharma India has shown a strong performance in the past 1 day and 1 month, with a 9.05% and 7.66% increase respectively. In contrast, the Sensex has only seen a marginal increase of 0.06% and 4.68% in the same time periods.

Astrazeneca Pharma India's success can be attributed to its strong presence in the pharmaceutical industry, with a focus on midcap companies. With its consistent performance and positive outlook, the company continues to be a promising player in the market.